Research will target specific regions of DNA strands to understand role of genetic variants
The NIH has selected OMRF to lead a $58.5 million public-private partnership aimed at developing more effective treatments for autoimmune diseases.
Clinical trial results illustrate incremental advances in lupus research.
Tens of thousands of patient samples have contributed to worldwide research.
Oklahoma’s lupus cohort marks 20 years.
The new millennium began with a bang at OMRF, as Dr. Jordan Tang, above, and his research team identified and cloned the enzyme believed to cause Alzheimer’s disease. Soon after, the OMRF scientists designed an inhibitor that stopped the enzyme in its tracks. The discoveries led to the development of an experimental drug acquired by […]